Outside (blue) and inside (red) populations are indicated. Signal intensities are shown, in comparison to the strongest signal, designated as 1. Two representative embryos are shown for each category. A total of 112 embryos were obtained from intercrosses, 53 embryos died prior to the morula stage, and genotypes could not be determined. All the other embryos appeared to be normal in terms of both morphology and Cdx2 expression. Among these, no Yap -/-; Wwtr1 -/-embryos were detected, suggesting that these had died prior to the morula stage.
SUPPLEMENTAL EXPERIMENTAL PROCEDURES Plasmids

Plasmids used for transfections and preparation of poly(A)-tailed RNAs included
protein-coding regions of Tead1, Tead4, Yap (Sawada et al., 2005) , Wwtr1, Lats2 (Ota and Sasaki, 2008) , Ssdp1 and Ndr1 (MGC ID 3484764), which were PCR-amplified from full-length cDNAs and cloned into pcDNA3.1-poly(A)83 vector (Yamagata et al., 2005) . Identities of the PCR-amplified sequences were confirmed by DNA sequencing. Tead4VP16 cDNA was generated by fusing amino acid residues 1 to 150 of Tead4 to the activation domain of herpes simplex virus (HSV) VP16, and includes an introduced ClaI site resulting in two additional amino acids (ID). Foxa2VP16 was generated by fusing the entire coding sequence of the Foxa2 cDNA and the activation domain of VP16. Tead4EnR was generated by fusing the repression domain of Engrailed (Kishi et al., 2000) , again using a ClaI site. Yap mutant cDNAs are described elsewhere (Ota and Sasaki, 2008) . Lats2-KD was generated by changing a conserved aspartate in kinase subdomain VII to an alanine (mouse Lats2 D768A, which corresponds to the human LATS2D809A (Chan et al., 2005) ). The pCAG-Tead4VP16ER-IP plasmid was generated by replacing the Cdx2 cDNA of pCAG-Cdx2ER-IP (Niwa et al., 2005) with Tead4VP16. For the luciferase assay, pCMV-Gal4(BD) and pG4-TK-Luc were as previously described (Sasaki et al., 1999) .
pCMV-Gal4-Tead4C was constructed by cloning the Tead4 cDNA fragment encoding the C-terminal portion of Tead4, corresponding to amino acid residues 97-427, to the pCMV-Gal4(BD) vector.
Semi-Guantitative RT-PCR
Primers (cycles) used for semi-quantitative RT-PCR were as follows: Yap (35 cycles) (ttcaatgccgtcatgaaccccaag, tcgaacatgctgtggagtcagagc), Wwtr1 (37 cycles) (attaggatgcgtcaagaggagctc, tctcatatctgtgctcatggcagg), Lats1 (40 cycles) (tttgcaggctgctggctttg, agacatctgctctcgacgag), Lats2 (40 cycles) (tgcgagtcatcaagcagacc, acttggctctactgctgtgc). PCR reaction conditions were as follows: 95 °C for 1 min, indicated cycles of 95 °C for 30 s, 58 °C for 30 s, 72 °C for 1 min, followed by 72 °C for 5 min.
Genotype Determination of Lats Mutant Embryos
Genotyping of preimplantation embryos was performed on individually isolated embryos after observation following antibody staining. All genotyping was performed by PCR with primers that produced both mutant and wild type bands. Lats1 and Lats2 alleles were genotyped using the following primers: Lats1F, GGTACTGTGTGAATGCAACC; Lats1R, GTGGAAGTAACTAACCTAGG; Lats2F, TGGTGAATGCGGGATGTGAC; Lats2R, CGTGTGCTTCAAATGCACAG;
PGK3'end, TGCCTGCTCTTTACTGAAGG. A 910 bp product is amplified from the Lats1 mutant allele using Lats1F and PGK3'end primers. A 763 bp product is amplified from the Lats1 wild type allele using Lats1F and Lats1R primers. A 330 bp product is amplified from the Lats2 mutant allele using Lats2F and PGK3'end primers. A 256 bp product is amplified from the Lats2 wild type allele using Lats2F and Lats2R primers.
PCR reaction conditions were as follows: 95 °C for 3 min, 40 cycles of 95 °C for 30 s, 56 °C for 30 s, 72 °C for 2 min, followed by 72 °C for 3 min. The position of the primers is indicated in Supplemental Figure S4A (Lats1) and S4B (Lats2).
Representative PCR results are shown in Supplemental Figure S4C .
Antibodies
Primary antibodies used for immunofluorescent staining included anti-β-catenin (C2206, Sigma) 1:4000, anti-Cdx2 (MU392-UC, BioGenex) 1:100, anti-E-cadherin (610181, BD Transduction Laboratories) 1:500, anti-Oct3/4 (Niwa et al., 2005) 1:5000, anti-Yap (Ota and Sasaki, 2008) 1:300, and essentially the same results were obtained with commercially available anti-Yap antibody (4912S, Cell signaling) 1:300, anti-p-Yap
